- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2018
- Public Summary Document (PSD) March 2018 PBAC Meeting - PDF
- Public Summary Document (PSD) March 2018 PBAC Meeting - Word
Ertugliflozin; ertugliflozin with metformin – March 2018
Ertugliflozin: Tablet containing 5 mg ertugliflozin, Tablet containing 15 mg ertugliflozin; Steglatro®; ertugliflozin with metformin: Tablet containing 2.5 mg ertugliflozin with 500 mg metformin hydrochloride, Tablet containing 2.5 mg ertugliflozin w
Last updated
29 June 2018